626 related articles for article (PubMed ID: 26469742)
21. Regio- and stereoselective synthesis of dispirooxindole-pyrrolocarbazole hybrids via 1,3-dipolar cycloaddition reactions: Cytotoxic activity and SAR studies.
Murali K; Sparkes HA; Rajendra Prasad KJ
Eur J Med Chem; 2018 Jan; 143():292-305. PubMed ID: 29197734
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Cytotoxic Evaluation of Pyran, Dihydropyridine and Thiophene Derivatives of 3-Acetylcoumarin.
Mohareb RM; Megally Abdo NY
Chem Pharm Bull (Tokyo); 2015; 63(9):678-87. PubMed ID: 26329861
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
24. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules.
Lu Y; Wang L; Wang X; Xi T; Liao J; Wang Z; Jiang F
Eur J Med Chem; 2017 Jul; 135():125-141. PubMed ID: 28441581
[TBL] [Abstract][Full Text] [Related]
25. Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling.
Malki A; Elbayaa RY; Ashour HM; Loffredo CA; Youssef AM
J Enzyme Inhib Med Chem; 2015; 30(5):786-95. PubMed ID: 25363687
[TBL] [Abstract][Full Text] [Related]
26. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents.
Md Tohid SF; Ziedan NI; Stefanelli F; Fogli S; Westwell AD
Eur J Med Chem; 2012 Oct; 56():263-70. PubMed ID: 22955095
[TBL] [Abstract][Full Text] [Related]
28. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.
Lafayette EA; de Almeida SMV; Cavalcanti Santos RV; de Oliveira JF; Amorim CADC; da Silva RMF; Pitta MGDR; Pitta IDR; de Moura RO; de Carvalho Júnior LB; de Melo Rêgo MJB; de Lima MDCA
Eur J Med Chem; 2017 Aug; 136():511-522. PubMed ID: 28531811
[TBL] [Abstract][Full Text] [Related]
30. In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties.
Rizzk YW; El-Deen IM; Mohammed FZ; Abdelhamid MS; Khedr AIM
Anticancer Agents Med Chem; 2019; 19(16):2010-2018. PubMed ID: 31566140
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents.
Reddy CN; Nayak VL; Mani GS; Kapure JS; Adiyala PR; Maurya RA; Kamal A
Bioorg Med Chem Lett; 2015 Oct; 25(20):4580-6. PubMed ID: 26330077
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition.
Panathur N; Dalimba U; Koushik PV; Alvala M; Yogeeswari P; Sriram D; Kumar V
Eur J Med Chem; 2013 Nov; 69():125-38. PubMed ID: 24013412
[TBL] [Abstract][Full Text] [Related]
34. New zirconium (IV) complexes of coumarins with cytotoxic activity.
Kostova I; Momekov G
Eur J Med Chem; 2006 Jun; 41(6):717-26. PubMed ID: 16697491
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents.
Amin KM; Eissa AA; Abou-Seri SM; Awadallah FM; Hassan GS
Eur J Med Chem; 2013 Feb; 60():187-98. PubMed ID: 23291120
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895
[TBL] [Abstract][Full Text] [Related]
38. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents.
Amin KM; Taha AM; George RF; Mohamed NM; Elsenduny FF
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29148081
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M
Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]